Royal Bank of Canada Lowers Teladoc Health (NYSE:TDOC) Price Target to $18.00

Teladoc Health (NYSE:TDOC) had its price objective trimmed by Royal Bank of Canada from $25.00 to $18.00 in a research report released on Friday, Benzinga reports. The brokerage currently has an outperform rating on the health services provider’s stock.

Other analysts have also recently issued research reports about the stock. DA Davidson lowered their target price on shares of Teladoc Health from $22.00 to $18.00 and set a neutral rating on the stock in a research note on Wednesday, February 21st. TD Cowen lowered their target price on shares of Teladoc Health from $16.00 to $15.00 and set a hold rating on the stock in a research note on Friday. Needham & Company LLC reissued a hold rating on shares of Teladoc Health in a research note on Friday. Stifel Nicolaus lowered their target price on shares of Teladoc Health from $21.00 to $16.00 and set a hold rating on the stock in a research note on Friday. Finally, SVB Leerink began coverage on shares of Teladoc Health in a research note on Monday, February 26th. They issued a market perform rating and a $17.00 target price on the stock. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health currently has an average rating of Hold and a consensus price target of $19.67.

Teladoc Health Stock Performance

Shares of TDOC opened at $13.01 on Friday. The company has a 50-day simple moving average of $15.01 and a 200-day simple moving average of $17.77. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. Teladoc Health has a 52 week low of $12.65 and a 52 week high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the company posted ($0.37) EPS. On average, equities research analysts forecast that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, CAO Richard J. Napolitano sold 3,765 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the transaction, the chief accounting officer now directly owns 18,077 shares in the company, valued at $262,478.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Teladoc Health news, CEO Jason N. Gorevic sold 53,755 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $780,522.60. Following the sale, the chief executive officer now directly owns 653,073 shares in the company, valued at $9,482,619.96. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Richard J. Napolitano sold 3,765 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the sale, the chief accounting officer now owns 18,077 shares in the company, valued at $262,478.04. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock worth $2,038,251 over the last ninety days. Company insiders own 1.63% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently bought and sold shares of the company. ICA Group Wealth Management LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $28,000. Hexagon Capital Partners LLC raised its holdings in shares of Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares during the period. RIA Advisory Group LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $36,000. GAMMA Investing LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $41,000. Finally, Principal Securities Inc. acquired a new stake in shares of Teladoc Health during the fourth quarter worth $45,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.